Occidental Asset Management, LLC Johnson & Johnson Transaction History

Occidental Asset Management, LLC

  • $785 Million
  • Q3 2025

A detailed history of Occidental Asset Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Occidental Asset Management, LLC holds 5,164 shares of JNJ stock, worth $1.03 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,164
Previous 3,992 29.36%
Holding current value
$1.03 Million
Previous $609,000 57.14%
% of portfolio
0.12%
Previous 0.08%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 28, 2025
BUY
$155.17 - $185.42 $181,859 - $217,312
1,172 Added 29.36%
5,164 $957,000
Q2 2025

Jul 14, 2025
BUY
$146.36 - $159.82 $98,646 - $107,718
674 Added 20.31%
3,992 $609,000
Q1 2025

May 15, 2025
SELL
$142.06 - $167.7 $28,696 - $33,875
-202 Reduced 5.74%
3,318 $550,000
Q4 2024

Jan 14, 2025
SELL
$143.34 - $165.86 $26,517 - $30,684
-185 Reduced 4.99%
3,520 $509,000
Q3 2024

Oct 11, 2024
BUY
$145.48 - $167.38 $42,043 - $48,372
289 Added 8.46%
3,705 $600,000
Q2 2024

Jul 15, 2024
BUY
$144.38 - $157.78 $87,638 - $95,772
607 Added 21.61%
3,416 $499,000
Q1 2024

Apr 16, 2024
SELL
$155.22 - $162.74 $620 - $650
-4 Reduced 0.14%
2,809 $444,000
Q4 2023

Jan 18, 2024
BUY
$145.6 - $158.88 $4,368 - $4,766
30 Added 1.08%
2,813 $440,000
Q3 2023

Oct 18, 2023
BUY
$155.75 - $174.48 $5,918 - $6,630
38 Added 1.38%
2,783 $433,000
Q2 2023

Jul 11, 2023
BUY
$154.35 - $166.11 $463 - $498
3 Added 0.11%
2,745 $454,000
Q1 2023

May 10, 2023
BUY
$151.05 - $180.26 $8,005 - $9,553
53 Added 1.97%
2,742 $425,000
Q3 2022

Nov 07, 2022
SELL
$161.33 - $179.52 $1,290 - $1,436
-8 Reduced 0.3%
2,689 $439,000
Q2 2022

Jul 18, 2022
BUY
$168.19 - $186.01 $2,018 - $2,232
12 Added 0.45%
2,697 $479,000
Q4 2021

Feb 01, 2022
BUY
$155.93 - $173.01 $467 - $519
3 Added 0.11%
2,685 $459,000
Q3 2021

Nov 03, 2021
BUY
$161.5 - $179.47 $323 - $358
2 Added 0.07%
2,682 $433,000
Q2 2021

Aug 17, 2021
BUY
$159.48 - $171.07 $956 - $1,026
6 Added 0.22%
2,680 $442,000
Q4 2020

Jan 28, 2021
BUY
$137.11 - $157.38 $45,931 - $52,722
335 Added 14.32%
2,674 $421,000
Q2 2020

Jul 17, 2020
SELL
$128.81 - $155.51 $28,982 - $34,989
-225 Reduced 8.78%
2,339 $329,000
Q1 2020

Apr 23, 2020
SELL
$111.14 - $153.99 $47,234 - $65,445
-425 Reduced 14.22%
2,564 $336,000
Q3 2019

Oct 17, 2019
SELL
$126.95 - $142.14 $15,234 - $17,056
-120 Reduced 3.86%
2,989 $387,000
Q2 2019

Aug 02, 2019
SELL
$131.15 - $144.24 $43,804 - $48,176
-334 Reduced 9.7%
3,109 $433,000
Q1 2019

May 15, 2019
BUY
$125.72 - $139.79 $140,806 - $156,564
1,120 Added 48.21%
3,443 $481,000
Q4 2018

Mar 19, 2019
SELL
$122.84 - $147.84 $89,918 - $108,218
-732 Reduced 23.96%
2,323 $300,000
Q2 2018

Mar 19, 2019
BUY
$119.4 - $131.76 $19,701 - $21,740
165 Added 5.71%
3,055 $371,000
Q1 2018

Mar 20, 2019
SELL
$125.1 - $148.14 $14,386 - $17,036
-115 Reduced 3.83%
2,890 $370,000
Q3 2017

Mar 19, 2019
SELL
$129.47 - $135.38 $12,947 - $13,538
-100 Reduced 3.22%
3,005 $391,000
Q2 2017

Mar 19, 2019
BUY
N/A
77 Added 2.54%
3,105 $411,000
Q1 2017

Mar 19, 2019
SELL
N/A
-40 Reduced 1.3%
3,028 $377,000
Q4 2016

May 15, 2019
SELL
N/A
-845 Reduced 21.59%
3,068 $353,000
Q3 2016

May 15, 2019
SELL
N/A
-236 Reduced 5.69%
3,913 $462,000
Q2 2016

May 15, 2019
BUY
N/A
1,679 Added 67.98%
4,149 $503,000
Q4 2015

Jun 17, 2019
SELL
N/A
-130 Reduced 5.0%
2,470 $254,000
Q3 2015

Jun 17, 2019
SELL
N/A
-200 Reduced 7.14%
2,600 $243,000
Q1 2015

Jun 17, 2019
SELL
N/A
-45 Reduced 1.58%
2,800 $282,000
Q4 2014

Jun 17, 2019
SELL
N/A
-656 Reduced 18.74%
2,845 $298,000
Q2 2014

Jun 17, 2019
SELL
N/A
-70 Reduced 1.96%
3,501 $366,000
Q1 2014

Jun 17, 2019
BUY
N/A
3,571
3,571 $329,000

Others Institutions Holding JNJ

# of Institutions
4,824
Shares Held
1.74B
Call Options Held
20.4M
Put Options Held
17.2M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Occidental Asset Management, LLC Portfolio

Follow Occidental Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occidental Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Occidental Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email